Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 4.6/5
Sichuan Expressway Co H (107 HK)
Watchlist
71
Analysis
Industrials
•
China
Sichuan Expressway Company Limited develops, invests in, and operates infrastructure projects including toll roads, bridges, tunnels, and ancillary facilities.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
29 Jun 2025 02:10
A-H Premium Weekly (Jun 27th): China Shenhua Energy, Bank Of Zhengzhou, Guolian Minsheng Securities
We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Shenhua Energy, Bank Of Zhengzhou, Guolian Minsheng...
Ke Yan, CFA, FRM
Follow
29 Views
Share
bullish
•
Zhejiang Expressway Co H
•
06 Oct 2024 23:30
Zhejiang Expressway (576 HK): Cheap Access to the Roaring Securities Sector
Zhejiang Expressway provides indirect cheap access to mainland securities through its ownership in Zheshang Securities, with a stable toll road...
Osbert Tang, CFA
Follow
445 Views
Share
bullish
•
Thematic (Sector/Industry)
•
06 Jun 2024 23:30
China Toll Road Sector: Higher for Longer......Yields
China's toll road sector has performed solidly since 2022, but is still offering attractive yields and healthy profit. Jiangsu Expressway stands...
Osbert Tang, CFA
Follow
538 Views
Share
bearish
•
Quantitative Analysis
•
08 Jun 2025 02:15
A-H Premium Weekly (Jun 6th): Jiangsu Expressway, Sichuan Expressway, CICC
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Jl Mag Rare-Earth, Jiangsu Expressway, Sichuan Expressway,...
Ke Yan, CFA, FRM
Follow
329 Views
Share
bearish
•
Quantitative Analysis
•
20 Apr 2025 02:10
A-H Premium Weekly (Apr 18th): Remegen, Shandong Gold Mining, Innocare Pharma
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Remegen, Shandong Gold Mining, Innocare Pharma, China...
Ke Yan, CFA, FRM
Follow
358 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.6
x